Jiangsu Lanfeng Bio-chemicalLtd Past Earnings Performance
Past criteria checks 0/6
Jiangsu Lanfeng Bio-chemicalLtd has been growing earnings at an average annual rate of 16.7%, while the Chemicals industry saw earnings growing at 7.9% annually. Revenues have been growing at an average rate of 1.2% per year.
Key information
16.7%
Earnings growth rate
19.4%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 1.2% |
| Return on equity | -178.5% |
| Net Margin | -20.0% |
| Next Earnings Update | 06 Aug 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Jiangsu Lanfeng Bio-chemicalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 1,738 | -348 | 171 | 40 |
| 31 Dec 23 | 1,742 | -332 | 174 | 15 |
| 30 Sep 23 | 1,117 | -445 | 158 | 15 |
| 30 Jun 23 | 1,148 | -411 | 140 | 14 |
| 31 Mar 23 | 1,388 | -336 | 119 | 13 |
| 01 Jan 23 | 1,445 | -321 | 104 | 12 |
| 30 Sep 22 | 1,449 | -461 | 137 | 5 |
| 30 Jun 22 | 1,627 | -479 | 159 | 8 |
| 31 Mar 22 | 1,549 | -492 | 175 | 11 |
| 01 Jan 22 | 1,444 | -491 | 175 | 13 |
| 30 Sep 21 | 1,349 | -38 | 157 | 15 |
| 30 Jun 21 | 1,404 | 11 | 156 | 12 |
| 31 Mar 21 | 1,438 | 31 | 155 | 14 |
| 31 Dec 20 | 1,342 | 15 | 177 | 16 |
| 30 Sep 20 | 1,398 | -533 | 387 | 23 |
| 30 Jun 20 | 1,295 | -548 | 399 | 30 |
| 31 Mar 20 | 1,378 | -545 | 421 | 32 |
| 31 Dec 19 | 1,504 | -517 | 425 | 35 |
| 30 Sep 19 | 1,518 | -812 | 327 | 37 |
| 30 Jun 19 | 1,351 | -884 | 384 | 37 |
| 31 Mar 19 | 1,395 | -889 | 393 | 41 |
| 31 Dec 18 | 1,481 | -875 | 410 | 45 |
| 30 Sep 18 | 1,696 | -93 | 406 | 55 |
| 30 Jun 18 | 1,918 | 5 | 326 | 82 |
| 31 Mar 18 | 1,916 | 42 | 346 | 70 |
| 31 Dec 17 | 1,851 | 35 | 342 | 58 |
| 30 Sep 17 | 1,735 | 113 | 309 | 34 |
| 30 Jun 17 | 1,628 | 104 | 335 | 0 |
| 31 Mar 17 | 1,507 | 96 | 319 | 0 |
| 31 Dec 16 | 1,457 | 107 | 317 | 0 |
| 30 Sep 16 | 1,263 | 58 | 262 | 0 |
| 30 Jun 16 | 1,115 | 4 | 257 | 0 |
| 31 Mar 16 | 1,038 | -32 | 244 | 0 |
| 31 Dec 15 | 1,010 | -69 | 234 | 0 |
| 30 Sep 15 | 1,067 | -63 | 202 | 0 |
| 30 Jun 15 | 1,144 | -49 | 178 | 0 |
| 31 Mar 15 | 1,253 | -45 | 155 | 0 |
| 31 Dec 14 | 1,252 | -37 | 137 | 0 |
| 30 Sep 14 | 1,277 | -19 | 131 | 0 |
| 30 Jun 14 | 1,322 | -4 | 134 | 0 |
| 31 Mar 14 | 1,345 | 8 | 147 | 0 |
| 31 Dec 13 | 1,372 | 21 | 155 | 0 |
| 30 Sep 13 | 1,396 | 44 | 165 | 0 |
Quality Earnings: 002513 is currently unprofitable.
Growing Profit Margin: 002513 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002513 is unprofitable, but has reduced losses over the past 5 years at a rate of 16.7% per year.
Accelerating Growth: Unable to compare 002513's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 002513 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-16.4%).
Return on Equity
High ROE: 002513 has a negative Return on Equity (-178.45%), as it is currently unprofitable.